1. Essential medicines list in national cancer control plans: a secondary analysis from a global study. Issue 3 (March 2022) Authors: Razis, Evangelia; Kassapian, Marie; Andriakopoulou, Charitini; Martei, Yehoda M; Zurn, Shalini Jayasekar; Hammad, Nazik; Romero, Yannick; Dafni, Urania; Ilbawi, André M; Trapani, Dario Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: e144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Retrospective cohort analysis of prescription patterns of cancer medications during periods of drug stockouts in Botswana. Issue 7 (12th July 2021) Authors: Davey, Sonya; Grover, Surbhi; Bilker, Warren B; Setlhako, Dipho I; Ralefala, Tlotlo B; Manshimba, Patrick; Gross, Robert; DeMichele, Angela; Shulman, Lawrence N; Martei, Yehoda M Journal: BMJ open Issue: Volume 11:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Shortages and price variability of essential cytotoxic medicines for treating children with cancers. Issue 11 (10th November 2020) Authors: Martei, Yehoda M; Iwamoto, Kotoji; Barr, Ronald D; Wiernkowski, John T; Robertson, Jane Journal: BMJ global health Issue: Volume 5:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗